What is my risk of developing Clostridioides difficile (C. difficile) infection after taking three doses of Augmentin (amoxicillin/clavulanate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of C. difficile Infection After Limited Augmentin Exposure

Your risk of developing C. difficile infection after taking only three doses of Augmentin (amoxicillin/clavulanate) is relatively low but still present, as even limited antibiotic exposure increases C. difficile risk compared to no antibiotic use.

Understanding Your Risk Level

The risk of C. difficile infection (CDI) after limited antibiotic exposure can be assessed based on several factors:

Duration of Exposure

  • You've taken only three doses of Augmentin, which represents a very short course
  • According to IDSA/SHEA guidelines, shorter antibiotic exposure carries less risk than longer courses 1
  • Even very limited exposure (such as single-dose surgical prophylaxis) can increase risk of C. difficile colonization and symptomatic disease 1

Timing of Risk

  • The highest risk period for CDI is during antibiotic therapy and within the first month after stopping antibiotics 1
  • The disruption of intestinal microbiota can persist for up to 3 months following antibiotic cessation 1
  • Your risk is highest now and will gradually decrease over the next month

Specific Antibiotic Risk

  • Amoxicillin/clavulanate has a moderate risk profile for CDI compared to higher-risk antibiotics like:
    • Clindamycin
    • Fluoroquinolones
    • Third/fourth-generation cephalosporins
    • Carbapenems 1
  • The FDA label for Augmentin specifically warns about the risk of C. difficile-associated diarrhea 2

Risk Quantification

While exact risk percentages for three doses are not available, we can make reasonable estimates:

  • A 7-day course of amoxicillin has been used as a reference point in comparative studies 3
  • Shorter courses (your three doses) would carry proportionally less risk
  • The absolute risk is likely less than 1% based on typical CDI rates after brief antibiotic exposure

Risk Modifiers

Your personal risk may be higher if you have any of these additional risk factors:

  • Advanced age
  • Recent hospitalization
  • Prior C. difficile infection
  • Use of proton pump inhibitors (PPIs) 1
  • Underlying gastrointestinal conditions
  • Immunosuppression

Monitoring and Prevention

  1. Watch for symptoms:

    • Three or more episodes of unexplained, unformed stools in 24 hours 4
    • Abdominal pain or cramping
    • Fever
  2. Preventive measures:

    • Practice good hand hygiene (soap and water is superior to alcohol-based sanitizers for C. difficile) 4
    • Avoid unnecessary additional antibiotics in the next 3 months if possible
    • Consider limiting use of acid-suppressing medications if you're taking them 1

When to Seek Medical Attention

Contact your healthcare provider promptly if you develop:

  • Persistent diarrhea (especially if severe)
  • Fever above 100.4°F (38°C)
  • Severe abdominal pain
  • Blood in stool

Remember that while your risk is present, the vast majority of people who take short courses of antibiotics do not develop C. difficile infection. Your brief exposure to Augmentin places you at lower risk than someone who completed a full 7-10 day course.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic Prescribing Choices and Their Comparative C. Difficile Infection Risks: A Longitudinal Case-Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Research

Clostridioides difficile Infection: Update on Management.

American family physician, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.